Beacon Pointe Advisors’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $205K | Hold |
|
|||||
|
2025
Q2 | $212K | Hold |
|
|||||
|
2025
Q1 | $197K | Hold |
|
|||||
|
2024
Q4 | $247K | Hold |
|
|||||
|
2024
Q3 | $131K | Hold |
|
|||||
|
2024
Q2 | $97.1K | Buy |
|
|||||
|
2024
Q1 | $91.6K | Hold |
|
|||||
|
2023
Q4 | $168K | Sell |
|
|||||
|
2023
Q3 | $119K | Buy |
|
|||||
|
2023
Q2 | $146K | Hold |
|
|||||
|
2023
Q1 | $154K | Hold |
|
|||||
|
2022
Q4 | $167K | Hold |
|
|||||
|
2022
Q3 | $186K | Hold |
|
|||||
|
2022
Q2 | $180K | Hold |
|
|||||
|
2022
Q1 | $222K | Sell |
|
|||||
|
2021
Q4 | $316K | Hold |
|
|||||
|
2021
Q3 | $327K | Hold |
|
|||||
|
2021
Q2 | $417K | Hold |
|
|||||
|
2021
Q1 | $272K | Hold |
|
|||||
|
2020
Q4 | $98K | Buy |
|